Four-year use of SGLT2i as adjunctive therapy in adults with type 1 diabetes: a real-world experience. in Acta diabetologica / Acta Diabetol. 2025 Feb 28. doi: 10.1007/s00592-025-02474-7.
2025
ASL Torino 4
ASL Torino 4
Tipo pubblicazione
Journal Article
Autori/Collaboratori (8)Vedi tutti...
Valenzano M
Division of Diabetology, Department of Internal Medicine, Local Health Service Torino 4, Corso Galileo Ferraris 3, 10034, Chivasso, TO, Italy. mvalenzano@aslto4.piemonte.it.
Massari L
Hospital Farmacy, Local Health Service Torino 4, Corso Galileo Ferraris 3, 10134, Chivasso, TO, Italy.
Abrate P
Hospital Farmacy, Local Health Service Torino 4, Corso Galileo Ferraris 3, 10134, Chivasso, TO, Italy.
et alii...
Division of Diabetology, Department of Internal Medicine, Local Health Service Torino 4, Corso Galileo Ferraris 3, 10034, Chivasso, TO, Italy. mvalenzano@aslto4.piemonte.it.
Massari L
Hospital Farmacy, Local Health Service Torino 4, Corso Galileo Ferraris 3, 10134, Chivasso, TO, Italy.
Abrate P
Hospital Farmacy, Local Health Service Torino 4, Corso Galileo Ferraris 3, 10134, Chivasso, TO, Italy.
et alii...
Accesso banca dati bibliografica
Accedi alla scheda bibliografica del documento in PUBMED
Se sei accreditato in BVS-P effettua prima l'accesso per utilizzare i nostri servizi.
PMID : 40019591
DOI : 10.1007/s00592-025-02474-7
Keywords
SGLT2i; Community health; Diabetes type 1; Ketoacidosis; Pharmacoeconomics; Real-world evidence;